Convatec Group PLC (LON:CTEC) Stock Has Average Target Price of GBX 305.44

Key Points

• Analysts maintain a Moderate Buy consensus on Convatec Group, with eight buy ratings and one hold. The average 12-month price target is GBX 305.44, above the reported share price of GBX 242.33.
• Several major firms remain positive, including Royal Bank of Canada, Deutsche Bank, Jefferies, and Berenberg, though Berenberg recently reduced its target from GBX 340 to GBX 335.
• Company insiders purchased shares: Tobias Hestler bought 50,000 shares and Jens Viebke bought 24,400 shares at prices between GBX 226 and GBX 230. Insiders collectively own 0.98% of the company.

Shares of Convatec Group PLC (LON:CTEC - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is GBX 305.44.

A number of equities analysts have weighed in on the company. Royal Bank Of Canada reissued an "outperform" rating and set a GBX 315 price target on shares of Convatec Group in a research report on Monday, August 3rd. Berenberg Bank cut their price objective on Convatec Group from GBX 340 to GBX 335 and set a "buy" rating for the company in a research report on Friday, September 11th. Peel Hunt reiterated an "add" rating and set a GBX 270 target price on shares of Convatec Group in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a GBX 315 target price on shares of Convatec Group in a report on Wednesday, August 5th. Finally, Jefferies Financial Group restated a "buy" rating and issued a GBX 300 price target on shares of Convatec Group in a research note on Wednesday, August 5th.

Insiders Place Their Bets

In related news, insider Tobias Hestler acquired 50,000 shares of the firm's stock in a transaction on Thursday, August 6th. The shares were purchased at an average cost of GBX 226 per share, for a total transaction of £113,000. Also, insider Jens Viebke acquired 24,400 shares of the company's stock in a transaction dated Tuesday, October 13th. The stock was bought at an average cost of GBX 230 per share, for a total transaction of £56,120. Insiders own 0.98% of the company's stock.

Convatec Group Trading Up 1.1%

Shares of LON:CTEC opened at GBX 242.33 on Friday. Convatec Group has a 52-week low of GBX 193 and a 52-week high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93. The company has a market capitalization of £4.65 billion, a P/E ratio of 39.09, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. The company has a 50-day simple moving average of GBX 224 and a 200 day simple moving average of GBX 218.44.

About Convatec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.